LON Longino & Cardenal S.p.A.
Longino & Cardenal S.p.A., together with its subsidiaries, engages in the distribution of food products in Italy, rest of the European Union, and internationally. It distributes food products through its online platform comprising caviar; fish products and specialties, such as oysters, mollusks, bivalves, canned fish, crustaceans, fish, and marine planktons; meats and cured meat products, including cattle, pigs, sheep, goats, farmyard animals, foie gras, and furred and feathered game birds; and Italian cheeses, butter, French cheeses, yogurt, and eggs. The company also offers fruits and vegetables, flowers, buds, aromatic herbs, garlic and black shallots, fruit and vegetable preserves, truffles, mushrooms, juices, crumble and crispy, and vegetable sheets; bread, breadsticks, pasta, rice, legumes, and flours, salt, spices, oil, vinegar, sauces, condiments, and molecular cuisine; and chocolates, pralines, cream and dessert products, nougats, and fruits and candied fruits. Longino & Cardenal S.p.A. was founded in 1988 and is based in Pogliano Milanese, Italy.…
Industry Peers
Food DistributionKey Statistics
About Longino & Cardenal (BIT: LON)
›
Longino & Cardenal (BIT: LON) is listed on Borsa Italiana, where its shares trade in EUR. It belongs to the Food Distribution industry, part of the Consumer Defensive sector, and reports about 59 employees.
The shares were at 1.290 EUR on 18 November 2026, up 17.3% over 52 weeks. Its 52-week range is 0.7450 EUR to 1.520 EUR: the price is 15.1% below the high and 73.2% above the low.
At a market capitalisation of 8.04M EUR, it trades at 10.8 times trailing earnings and 12.9 times forward earnings. The median trailing P/E of its 18 largest Food Distribution peers is 15.4, a discount of 30% for LON.
Longino & Cardenal reports return on equity of -22.7%, an operating margin of 3.7% and revenue down 7.9% year over year.
Its debt exceeds its cash by 5.41M EUR, a debt-to-equity ratio of 2.36. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 3 analysts cover the stock; their mean price target of 2.550 EUR is 97.7% above the current price.